Takeda Pharmaceutical Co., Ltd. et al v. Impax Laboratories, Inc.,

Filing 53

ORDER re 50 Stipulation of Dismissal of Count XI (False Marking) without prejudice filed by Impax Laboratories, Inc. Motions terminated: 20 MOTION to Dismiss Count XI of Impax's Counterclaims filed by Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals LLC. Signed by Judge Joseph C. Spero on 10/13/11. (klhS, COURT STAFF) (Filed on 10/14/2011)

1
2
3
4
5
6
7
8

UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

9
10
11
12

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND
TAKEDA PHARMACEUTICALS
AMERICA, INC.,

13
Plaintiffs,
14

Case No. 3:11-cv-01610-JCS
[PROPOSED] ORDER ON STIPULATION
OF DISMISSAL PURSUANT TO FED. R.
CIV. P. 41(a)(1) and (c)
Related Cases:
3:11-cv-00840-JCS
3:11-cv-01609-JCS

v.
15
IMPAX LABORATORIES, INC.,
16
Defendant.
17
18
19

Having considered the parties’ Stipulation of Dismissal of Count XI (False Marking) of
Defendant Impax’s Counterclaims (“Count XI”), IT IS ORDERED that Count XI is hereby

21

dismissed without prejudice, with each party to bear its own costs.

22

SO ORDERED:

23

October 13
DATED: __________________, 2011
_______________________________________
THE HONORABLE JOSEPH C. SPERO
o
UNITED STATES MAGISTRATE JUDGE
C. Sper
e Joseph

27
28

A

H

ER

FO

Judg

LI

RT

26

R NIA

NO

25

UNIT
ED

24

ISTRIC
ES D
TC
AT
T

RT
U
O

S

20

N

F
D IS T IC T O
R

C

la-1144345
[PROPOSED] ORDER ON STIPULATION OF
DISMISSAL